CDRH: CANCER BLOOD TESTS ISSUES BEYOND THE SCOPE OF FDA AUTHORITIES

Press/Media

Period1 Dec 2023

Media coverage

2

Media coverage

  • TitleCDRH: CANCER BLOOD TESTS ISSUES BEYOND THE SCOPE OF FDA AUTHORITIES
    Media name/outletFDA Week
    Country/TerritoryUnited States
    Date1/12/23
    PersonsMary Kemeny
  • TitleCDRH: Concerns Over Emerging Cancer Blood Tests Beyond The Scope Of FDA Authorities
    Media name/outletInside Health Policy
    Country/TerritoryUnited States
    Date1/12/23
    PersonsMary Kemeny